MIT researchers have developed microparticles that could be used to create self-boosting vaccines, saving us time and money, and more effectively curbing the spread of germs.
Patients with refractory schizophrenia in long-term forensic facilities show significant stabilization after reduced doses of long-acting injectable antipsychotics, new research suggests.
Patients with severe schizophrenia and resistance to standard doses of second-generation antipsychotics show significant improvement and tolerance for higher maintenance doses, new research suggests.